These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3553053

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical use of the quinolones.
    Neu HC.
    Lancet; 1987 Dec 05; 2(8571):1319-22. PubMed ID: 2890913
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Quinolones in the treatment of serious infections.
    Webster A, Gaya H.
    Rev Infect Dis; 1988 Dec 05; 10 Suppl 1():S225-33. PubMed ID: 3279496
    [Abstract] [Full Text] [Related]

  • 31. Quinolones.
    Shah PM.
    Prog Drug Res; 1987 Dec 05; 31():243-56. PubMed ID: 3326031
    [No Abstract] [Full Text] [Related]

  • 32. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Dec 05; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 33. Antibacterial activity of ofloxacin and its mode of action.
    Sato K, Inoue Y, Fujii T, Aoyama H, Mitsuhashi S.
    Infection; 1986 Dec 05; 14 Suppl 4():S226-30. PubMed ID: 3028966
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of 4-quinolones in the treatment of infections.
    Cynamon MH, Wilcox GH.
    Compr Ther; 1987 Feb 05; 13(2):37-43. PubMed ID: 3545658
    [No Abstract] [Full Text] [Related]

  • 38. The mode of action of 4-quinolones and possible mechanisms of resistance.
    Smith JT.
    J Antimicrob Chemother; 1986 Nov 05; 18 Suppl D():21-9. PubMed ID: 3542946
    [Abstract] [Full Text] [Related]

  • 39. CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Fuchs PC, Barry AL, Jones RN, Thornsberry C, Ayers LW, Gavan TL, Gerlach EH.
    Diagn Microbiol Infect Dis; 1987 Mar 05; 6(3):185-92. PubMed ID: 3471371
    [Abstract] [Full Text] [Related]

  • 40. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R, Lister D, McNulty CA, Griggs D, Andrews JM.
    Infection; 1986 Mar 05; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.